The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II clinical trial of a fasting-mimic diet prior to chemotherapy to evaluate the impact on toxicity and efficacy.
 
Tanya B. Dorff
Honoraria - Astellas Pharma; Dendreon; Exelixis; Pfizer; Prometheus
Consulting or Advisory Role - Bayer; Dendreon; Eisai; EMD Serono; Janssen Oncology
Speakers' Bureau - Astellas Pharma; Dendreon; Exelixis; Pfizer; Prometheus
Research Funding - Bayer; Bristol-Myers Squibb
 
Mahshid Shelechi
Employment - L-Nutra
Stock and Other Ownership Interests - L-Nutra
 
Irene Kang
Honoraria - Puma Biotechnology
Travel, Accommodations, Expenses - Peachtree Bioresearch Solutions
 
Todd E Morgan
Employment - L-Nutra
Leadership - L-Nutra
Stock and Other Ownership Interests - L-Nutra
Research Funding - L-Nutra
 
Susan G. Groshen
No Relationships to Disclose
 
Sriram Yennu
Research Funding - Bayer (Inst); Genentech/Roche (Inst); Helsinn Therapeutics (Inst)
 
Agustin A. Garcia
Honoraria - Pfizer
Consulting or Advisory Role - Amgen; Novartis
Research Funding - Advenchen Laboratories (Inst); Boston Biomedical (Inst); Celldex (Inst)
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Eisai; EMD Serono; Exelixis; Genentech/Roche; Janssen Oncology; Merck Sharp & Dohme; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Valter Longo
Leadership - L-Nutra
Stock and Other Ownership Interests - L-Nutra
Patents, Royalties, Other Intellectual Property - University of Southern California
Travel, Accommodations, Expenses - L-Nutra